Argentina's CILFA Joins IGBA

National Industry Association Joins Global Body As Associate Member

Argentina’s off-patent industry association, CILFA, has joined global body the IGBA as an associate member.

Argentina_Flag
Argentina’s CILFA body has joined the IGBA as an associate member • Source: Shutterstock

Argentinian off-patent industry association Cámara Industrial de Laboratorios Farmacéuticos Argentinos, or CILFA, has joined the International Generic and Biosimilar medicines Association as an IGBA associate member.

Noting that CILFA represented 38 generics and biosimilars manufacturers, together holding a 68% share of the Argentinian market in 2019,...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.